What was the overall market valuation of the GCC opioids market in 2024?

The overall market valuation was $1415.7 Million in 2024. Read More

What is the projected market valuation for the GCC opioids market by 2035?

The projected market valuation for 2035 is $1800.6 Million. Read More

What is the expected CAGR for the GCC opioids market during the forecast period 2025 - 2035?

The expected CAGR for the GCC opioids market during the forecast period 2025 - 2035 is 2.21%. Read More

Which segment had the highest valuation in the GCC opioids market in 2024?

The Pain Management segment had the highest valuation at $800.0 - $1000.0 Million in 2024. Read More

What are the key players in the GCC opioids market?

Key players include Purdue Pharma, Johnson & Johnson, Teva Pharmaceutical Industries, and others. Read More

What was the valuation range for Semi-synthetic Opioids in 2024?

The valuation range for Semi-synthetic Opioids was $500.0 - $600.0 Million in 2024. Read More

How did the valuation of Chronic Pain Patients segment perform in 2024?

The valuation for Chronic Pain Patients was between $500.0 - $650.0 Million in 2024. Read More

What is the projected growth for the Injectable route of administration by 2035?

The Injectable route of administration is projected to grow to $300.0 - $350.0 Million by 2035. Read More

What therapeutic application segment is expected to see growth in the GCC opioids market?

The Cough Suppression segment is expected to grow, with a valuation range of $300.0 - $350.0 Million. Read More

What is the valuation range for Fully Synthetic Opioids in 2024?

The valuation range for Fully Synthetic Opioids was $400.0 - $500.0 Million in 2024. Read More

GCC Opioids Market

GCC Opioids Market Research Report By Type (Natural Opioids, Semi-Synthetic Opioids, Fully Synthetic Opioids), By Application (Pain Management, Anesthesia, Cough Suppression, Diarrhea Treatment), By Route of Administration (Oral, Injectable, Transdermal, Topical) and By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) - Growth & Industry Forecast 2025 To 2035

Forecast Period

2025 - 2035

CAGR

2.21%

2024 Market Size

$ 1,415.7 Million

2035 Market Size

$ 1,800.6 Million

Healthcare ● Updated August 2026 Report ID: MRFR/HC/51509-HCR | Pages: 200 | Author: Rahul Gotadki, Garvit Vyas

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Chemicals and Materials, BY Type (USD Million)
  1. 4.1.1 Natural Opioids
  2. 4.1.2 Semi-synthetic Opioids
  3. 4.1.3 Fully Synthetic Opioids
  4. 4.1.4 Opioid Derivatives
2. 4.2 Chemicals and Materials, BY Route of Administration (USD Million)
  1. 4.2.1 Oral
  2. 4.2.2 Injectable
  3. 4.2.3 Transdermal
  4. 4.2.4 Rectal
  5. 4.2.5 Nasal
3. 4.3 Chemicals and Materials, BY Therapeutic Application (USD Million)
  1. 4.3.1 Pain Management
  2. 4.3.2 Cough Suppression
  3. 4.3.3 Diarrhea Treatment
  4. 4.3.4 Anesthesia
4. 4.4 Chemicals and Materials, BY Patient Population (USD Million)
  1. 4.4.1 Chronic Pain Patients
  2. 4.4.2 Postoperative Pain Patients
  3. 4.4.3 Cancer Patients
  4. 4.4.4 Palliative Care Patients
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Chemicals and Materials
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Chemicals and Materials
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Purdue Pharma (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Johnson & Johnson (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Teva Pharmaceutical Industries (IL)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Mundipharma (GB)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Endo International (IE)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Mallinckrodt Pharmaceuticals (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Amgen (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Boehringer Ingelheim (DE)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 GCC MARKET ANALYSIS BY TYPE
3. 6.3 GCC MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
4. 6.4 GCC MARKET ANALYSIS BY THERAPEUTIC APPLICATION
5. 6.5 GCC MARKET ANALYSIS BY PATIENT POPULATION
6. 6.6 KEY BUYING CRITERIA OF CHEMICALS AND MATERIALS
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF CHEMICALS AND MATERIALS
9. 6.9 DRIVERS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
10. 6.10 RESTRAINTS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
11. 6.11 SUPPLY / VALUE CHAIN: CHEMICALS AND MATERIALS
12. 6.12 CHEMICALS AND MATERIALS, BY TYPE, 2024 (% SHARE)
13. 6.13 CHEMICALS AND MATERIALS, BY TYPE, 2024 TO 2035 (USD Million)
14. 6.14 CHEMICALS AND MATERIALS, BY ROUTE OF ADMINISTRATION, 2024 (% SHARE)
15. 6.15 CHEMICALS AND MATERIALS, BY ROUTE OF ADMINISTRATION, 2024 TO 2035 (USD Million)
16. 6.16 CHEMICALS AND MATERIALS, BY THERAPEUTIC APPLICATION, 2024 (% SHARE)
17. 6.17 CHEMICALS AND MATERIALS, BY THERAPEUTIC APPLICATION, 2024 TO 2035 (USD Million)
18. 6.18 CHEMICALS AND MATERIALS, BY PATIENT POPULATION, 2024 (% SHARE)
19. 6.19 CHEMICALS AND MATERIALS, BY PATIENT POPULATION, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 GCC MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY ROUTE OF ADMINISTRATION, 2025-2035 (USD Million)
  3. 7.2.3 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Million)
  4. 7.2.4 BY PATIENT POPULATION, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

GCC Opioids Market Segmentation

GCC Opioids Market By Type (USD Million, 2025-2035)

Natural Opioids
Semi-synthetic Opioids
Fully Synthetic Opioids
Opioid Derivatives

GCC Opioids Market By Route of Administration (USD Million, 2025-2035)

Oral
Injectable
Transdermal
Rectal
Nasal

GCC Opioids Market By Therapeutic Application (USD Million, 2025-2035)

Pain Management
Cough Suppression
Diarrhea Treatment
Anesthesia

GCC Opioids Market By Patient Population (USD Million, 2025-2035)

Chronic Pain Patients
Postoperative Pain Patients
Cancer Patients
Palliative Care Patients

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”